Radiotherapy and COVID-19-everything under control or just the start of a long story?

Strahlenther Onkol. 2020 Dec;196(12):1065-1067. doi: 10.1007/s00066-020-01704-x.

Ursula Nestle^{1

2

3}, Mechthild Krause^{4

5

6

7

8}

¹ Klinik für Strahlentherapie und Radioonkologie, Kliniken Mariahilf Mönchengladbach, Mönchengladbach, Germany. ursula.nestle@mariahilf.de.
² Klinik für Strahlenheilkunde, Universitätsklinikum Freiburg, Freiburg, Germany. ursula.nestle@mariahilf.de.
³ German Cancer Consortium (DKTK) partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany. ursula.nestle@mariahilf.de.
⁴ German Cancer Consortium (DKTK) partner site Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁵ OncoRay-National Center for Radiation Research in Oncology: Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
⁶ Dept. of Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
⁷ Institute of Radiooncology-OncoRay, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
⁸ National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Faculty of Medicine, University Hospital C.G. Carus Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.

No abstract available

Publication types